By John Schroyer and Omar Sacirbey

New York tweaks its medical marijuana program, a Rhode Island MMJ committee meets eight years after its formation, and a new cannabis advocacy group is born.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
March 24, 2017

Industry officials encouraged as Florida’s medical cannabis law takes shape

Omar Sacirbey  | March 23, 2017

By Omar Sacirbey

After months of uncertainty, Florida’s new medical marijuana program is starting to come together and industry officials believe the number of MMJ business licenses will be expanded beyond the seven companies currently licensed under the state’s CBD-focused program.

Omar Sacirbey  |
March 23, 2017

Court-appointed receivers an option for troubled marijuana companies

John Schroyer  | March 22, 2017

By John Schroyer

Business partnerships in the cannabis industry have become increasingly common. But what happens when such a partnership goes down the tubes and the parties wind up in court?

In that situation, who’s left to run day-to-day operations?

John Schroyer  |
March 22, 2017

What’s in a strain name? Q&A with Canndescent CEO Adrian Sedlin

Bart Schaneman  | March 21, 2017

By Bart Schaneman

Walk into any marijuana outlet and you'll find jars of flower strains with names like Golden Goat, Ghost Train Haze or Robert Plant.

Such names convey minimal information to novice consumers, forcing them to do further research before they can purchase any cannabis. California-based cultivator Canndescent is trying to simplify that experience.

Bart Schaneman  |
March 21, 2017

Chart: Licensing bottlenecks hamper growth of Massachusetts MMJ program

Eli McVey  | March 20, 2017

By Eli McVey

Still reeling from a sluggish start statewide, Massachusetts’ medical marijuana program also is hindered by local-level licensing bottlenecks that have allowed just a handful of dispensaries to open to serve nearly 35,000 MMJ patients throughout the state.

Eli McVey  |
March 20, 2017

Week in Review: Sessions’ cannabis remarks, Oxford MMJ research & odd pairing in MA

John Schroyer  | March 17, 2017

By John Schroyer, Bart Schaneman and Omar Sacirbey

Attorney General Jeff Sessions again criticizes marijuana without offering a clear policy plan, Oxford University receives millions to study medical cannabis, and Massachusetts liquor store owners are eyeing the rec MJ market.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
March 17, 2017

Cannabis public use measures could spur MJ sales, businesses

Bart Schaneman  | March 16, 2017

By Bart Schaneman

From Alaska to Massachusetts, a number of states are weighing measures to allow people to consume cannabis in public places such as clubs and other venues.

Legalizing cannabis clubs and other venues for public consumption could spur MJ sales and create new business opportunities, said industry officials.

Bart Schaneman  |
March 16, 2017